ArticleJournal of arrhythmia2025
Clinical feasibility of high-power short-duration strategy at the sites adjacent to the esophagus during laser balloon-based pulmonary vein isolation.
Article in Journal of arrhythmia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Laser balloon-based pulmonary vein isolation is an established therapeutic option for atrial fibrillation. However, elevated esophageal temperature is sometimes problematic and increases the risk of collateral esophageal damage. This study aimed to evaluate the efficacy and safety of different power settings at sites where sudden esophageal temperature increases were documented. Methods: We enrolled 50 ablation sites in 11 patients where the esophageal temperature reached 39°C within 5 s after ablation. We applied four power settings (12, 10, 8.5, and 5.5 W), and ablation was immediately stopped when the esophageal temperature reached 39°C. Efficacy outcomes included ablation time and total energy, calculated as the product of power and ablation time. Safety outcomes included maximal esophageal temperature and area under the temperature-time curve above 39°C. Results: Although ablation time was the longest in the 5.5 W group (12 W: 3.1 ± 2.1 s, 10 W: 3.6 ± 2.7 s, 8.5 W: 4.7 ± 3.9 s, 5.5 W: 8.0 ± 7.2 s; Conclusions: A high-power, short-duration strategy might allow comparable energy application without excessive esophageal collateral damage, as estimated by the esophageal temperature. However, further research using gastrointestinal endoscopy to evaluate esophageal injury is needed to confirm our results.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.